泰地罗新注射液对猪传染性胸膜肺炎的临床疗效试验 |
| |
引用本文: | 贾兴,张星,张沛. 泰地罗新注射液对猪传染性胸膜肺炎的临床疗效试验[J]. 中国兽药杂志, 2022, 56(7): 54-59 |
| |
作者姓名: | 贾兴 张星 张沛 |
| |
作者单位: | 河北远征药业有限公司,, |
| |
摘 要: | 将泰地罗新注射液分为高、中、低(8、4、2 mg /kg bw)3个剂量组分别肌肉注射治疗猪传染性胸膜肺炎,同时设默沙东动物保健品有限公司的泰地罗新注射液为对照组,按4mg /kg bw给药,给药一次。结果表明,泰地罗新注射液中(4mg/kg bw)、高(8mg/kg bw)剂量对人工感染传染性胸膜肺炎病猪的有效率和治愈率无显著差异(P>0.05),与默沙东动物保健品有限公司生产的泰地罗新注射液推荐剂量(4mg/kg bw)的效果相当。试验结果表明泰地罗新注射液按一次量,每1 kg体重4mg肌注,对猪传染性胸膜肺炎有良好的治疗效果。
|
关 键 词: | 泰地罗新注射液;猪;传染性胸膜肺炎;临床疗效 |
收稿时间: | 2022-02-14 |
修稿时间: | 2022-06-30 |
Clinical effect of Tildipirosin injection on porcine infectious pleuropneumonia |
| |
Abstract: | Tildipirosin injection was divided into three groups of high, medium and low doses (8, 4, 2 mg /kg BW) for the treatment of porcine infectious pleuropneumonia by intramuscular injection. Meanwhile, Tildipirosin injection from MSD Animal Health Products Co., LTD was set as the control group, and was given 4mg /kg BW once. The results showed that there was no significant difference in the effective rate and cure rate between medium (4mg/kg BW) and high (8mg/kg BW) doses of Tildipirosin injection in artificially infected pigs with infectious pleuralpneumonia (P>0.05), which was similar to the recommended dose of Tidiloxin injection produced by MSD Animal Health Products Co., LTD. (4mg/kg BW).The results showed that Tildipirosin injection has a good therapeutic effect on porcine infectious pleuropneumonia by intramuscular injection of 4mg per 1 kg body weight. |
| |
Keywords: | |
|
| 点击此处可从《中国兽药杂志》浏览原始摘要信息 |
|
点击此处可从《中国兽药杂志》下载全文 |
|